TET2 regulates immune tolerance in chronically activated mast cells.

Saved in:
Bibliographic Details
Title: TET2 regulates immune tolerance in chronically activated mast cells.
Authors: Rigo R; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Chelbi R; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France.; Inovarion, Paris, France., Agopian J; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Letard S; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Griffon A; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Ghamlouch H; INSERM, Mixed Research Unit (UMR) 1170, Institut Gustave Roussy, Facility of Medicine, Paris-Sud University, Paris-Saclay University, Equipe Labélisée Ligue Nationale Contre le Cancer, Villejuif, France., Vernerey J; CRCM, Institut Paoli-Calmettes, Inserm, CNRS, Aix Marseille University, Marseille, France., Ladopoulos V; Department of Haematology, Cambridge Institute for Medical Research, and.; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Voisset E; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., De Sepulveda P; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Guittard G; CRCM, Institut Paoli-Calmettes, Inserm, CNRS, Aix Marseille University, Marseille, France., Nunès JA; CRCM, Institut Paoli-Calmettes, Inserm, CNRS, Aix Marseille University, Marseille, France., Bidaut G; CRCM, Institut Paoli-Calmettes, Inserm, CNRS, Aix Marseille University, Marseille, France., Göttgens B; Department of Haematology, Cambridge Institute for Medical Research, and.; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Weber M; CNRS, University of Strasbourg, UMR7242 Biotechnology and Cell Signaling, Illkirch, France., Bernard OA; INSERM, Mixed Research Unit (UMR) 1170, Institut Gustave Roussy, Facility of Medicine, Paris-Sud University, Paris-Saclay University, Equipe Labélisée Ligue Nationale Contre le Cancer, Villejuif, France., Dubreuil P; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France., Soucie E; Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Aix-Marseille University, Institut Paoli-Calmettes, Equipe Labélisée Ligue Nationale Contre le Cancer, Marseille, France.
Source: JCI insight [JCI Insight] 2022 Apr 08; Vol. 7 (7). Date of Electronic Publication: 2022 Apr 08.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.154191